The proto-oncogene LRF is under post-transcriptional control of MiR-20a: Implications for senescence

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Poliseno, Laura ^a,b   Pitto, Letizia ^a   Simili, Marcella ^a   Mariani, Laura ^a   Riccardi, Luisa ^b   Ciucci, Alessia ^a   Rizzo, Milena ^a   Evangelista, Monica ^a   Mercatanti, Alberto ^a   Pandolfi, Pier Paolo ^b   Rainaldi, Giuseppe ^a,c  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c ISTITUTO TOSCANO TUMORI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; LEUKEMIA RELATED FACTOR; LYMPHOMA RELATED FACTOR; MICRORNA; ONCOPROTEIN; P19ARF PROTEIN; PROTEIN P16; TRANSCRIPTION FACTOR E2F1; CDKN2A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA BINDING PROTEIN; E2F1 PROTEIN, MOUSE; MIRN20 MICRORNA, MOUSE; TRANSCRIPTION FACTOR; ZBTB7A PROTEIN, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL AGING; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MITOSIS INHIBITION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; TRANSCRIPTION REGULATION; WILD TYPE; ANIMAL; CELL PROLIFERATION; DOWN REGULATION; FIBROBLAST; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTO ONCOGENE; RNA INTERFERENCE;

MUS;

ANIMALS; BASE SEQUENCE; CELL AGING; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; DOWN-REGULATION; E2F1 TRANSCRIPTION FACTOR; FIBROBLASTS; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENES; RNA INTERFERENCE; TRANSCRIPTION FACTORS;

EID: 49749136970     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002542     Document Type: Article

References (47)

1. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr, et al. (1998) Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391: 811-814.
2. Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, et al. (1993) Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. Embo J 12: 1161-1167.
3. Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86.
4. Ye BH, Lista F, Lo Coco F, Knowles DM, Ollit K, et al. (1993) Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262: 747-750.
5. Davies JM, Hawe N, Kabarowski J, Huang QH, Zhu J, et al. (1999) Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18: 365-375.
6. Laudes M, Christodoulides C, Sewter C, Rochford JJ, Considine RV, et al. (2004) Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis. J Biol Chem 279: 11711-11718.
7. Liu CJ, Prazak L, Fajardo M, Yu S, Tyagi N, et al. (2004) Leukemia/ lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis. J Biol Chem 279: 47081-47091.
8. Maeda T, Hobbs RM, Pandolfi PP (2005) The transcription factor Pokemon: a new key player in cancer pathogenesis. Cancer Res 65: 8575-8578.
9. Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, et al. (2005) Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433: 278-285.
10. Palmero I, Pantoja C, Serrano M (1998) p19ARF links the tumour suppressor p53 to Ras. Nature 395: 125-126.
11. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
12. Engels BM, Hutvagner G (2006) Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 25: 6163-6169.
13. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
14. Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, et al. (2007) Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 109: 4399-4405.
15. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, et al. (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632.
16. Shao J, Li Y, Wu Q, Liang X, Yu X, et al. (2002) High frequency loss of heterozygosity on the long arms of chromosomes 13 and 14 in nasopharyngeal carcinoma in Southern China. Chin Med J (Engl) 115: 571-575.
17. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524-15529.
18. Lin YW, Sheu JC, Liu LY, Chen CH, Lee HS, et al. (1999) Loss of heterozygosity at chromosome 13q in hepatucellular carcinoma: identification of three independent regions. Eur J Cancer 35: 1730-1734.
19. Eaiksdottir G, Johannesdottir G, Ingvarsson S, Bjornsdottir IB, Jonasson JG, et al. (1998) Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Eur J Cancer 34: 2076-2081.
20. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
21. Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, et al. (2006) An E2F/miR-20a auto-regulatory feed-back loop. J Biol Chem.
22. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, et al. (2006) Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38: 1060-1065.
23. Woods K, Thomson JM, Hammond SM (2006) Direct regulation of an oncogenic microRNA cluster by E2F transcription factors. J Biol Chem.
24. Hossain A, Kuo MT, Saunders GF (2006) Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 26: 8191-8201.
25. Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, et al. (2005) Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 33: 2697-2706.
26. Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, et al. (2003) Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 5: 741-747.
27. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
28. Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, et al. (2006) Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 8: 1291 1297.
29. Yogev O, Anzi S, Inoue K, Shaulian E (2006) Induction of transcriptionally active Jun proteins regulates drug-induced senescence. J Biol Chem 281: 34475-34483.
30. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, et al. (1997) Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91: 649-659.
31. Carnero A, Hudson JD, Hannon GJ, Beach DH (2000) Loss-of-function genetics in mammalian cells: the p53 tumor suppressor models. Nucleic Acids Res 28: 2234-2241.
32. Lloyd AC (2002) Limits to lifespan. Nat Cell Biol 4: E25-27.
33. Mendell JT (2005) MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 4: 1179-1184.
34. Tuccoli A, Poliseno L, Rainaldi G (2006) miRNAs Regulate miRNAs: Coordinated Transcriptional and Post-Transcriptional Regulation. Cell Cycle 5.
35. Bates S, Phillips AC, Clark PA, Stott F, Peters G, et al. (1998) p14ARF links the tumour suppressors RB and p53. Nature 395: 124-125.
36. Dimri GP, Itahana K, Acosta M, Campisi J (2000) Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol Cell Biol 20: 273-285.
37. Martelli F, Hamilton T, Silver DP, Sharpless NE, Bardeesy N, et al. (2001) p19ARF targets certain E2F species for degradation. Proc Natl Acad Sci U S A 98: 4455-4460.
38. Mason SL, Loughran O, La Thangue NB (2002) p14(ARF) regulates E2F activity. Oncogene 21: 4220-4230.
39. Rizos H, Scurr LL, Irvine M, Alling NJ, Kefford RF (2007) p14ARF regulates E2F-1 ubiquitination and degradation via a p53-dependent mechanism. Cell Cycle 6: 1741-1747.
40. Maehara K, Yamakoshi K, Ohtani N, Kubo Y, Takahashi A, et al. (2005) Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53. J Cell Biol 168: 553-560.
41. Park C, Lee I, Kang WK (2006) E2F-1 is a critical modulator of cellular senescence in human cancer. Int J Mol Med 17: 715-720.
42. Canepa ET, Scassa ME, Ceruti JM, Marazita MC, Carcagno AL, et al. (2007) INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life 59: 419-426.
43. Iida S, Hirota T, Morisaki T, Marumoto T, Hara T, et al. (2004) Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G1 tetraploidy checkpoint function. Oncogene 23: 5266-5274.
44. Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q, et al. (2005) Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem 280: 9330-9335.
45. Thalmeier K, Synovzik H, Mertz R, Winnacker EL, Lipp M (1989) Nuclear factor E2F mediates basic transcription and trans-activation by Ela of the human MYC promoter. Genes Dev 3: 527-536.
46. Adams MR, Sears R, Nuckolls F, Leone G, Nevins JR (2000) Complex transcriptional regulatory mechanisms control expression of the E2F3 locus. Mol Cell Biol 20: 3633-3639.
47. Guney I, Wu S, Sedivy JM (2006) Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a). Proc Natl Acad Sci U S A 103: 3645-3650.